vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and GAIA, INC (GAIA). Click either name above to swap in a different company.
GAIA, INC is the larger business by last-quarter revenue ($25.5M vs $13.8M, roughly 1.9× FENNEC PHARMACEUTICALS INC.). GAIA, INC runs the higher net margin — -0.3% vs -34.7%, a 34.4% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 5.8%). Over the past eight quarters, GAIA, INC's revenue compounded faster (9.4% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Gaia, Inc. is a publicly traded (NASDAQ:GAIA) American media company founded in 1988 by Jirka Rysavy in Louisville, Colorado. It owns and operates Gaia TV, a subscription video on-demand service consisting of original and licensed alternative media documentaries, including those on wellness, spirituality and conspiracy theories.
FENC vs GAIA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $25.5M |
| Net Profit | $-4.8M | $-75.0K |
| Gross Margin | — | 87.6% |
| Operating Margin | -18.5% | -2.6% |
| Net Margin | -34.7% | -0.3% |
| Revenue YoY | 73.8% | 5.8% |
| Net Profit YoY | -141.1% | 91.7% |
| EPS (diluted) | $-0.17 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $25.5M | ||
| Q3 25 | $12.5M | $25.0M | ||
| Q2 25 | $9.7M | $24.6M | ||
| Q1 25 | $8.8M | $23.8M | ||
| Q4 24 | $7.9M | $24.1M | ||
| Q3 24 | $7.0M | $22.0M | ||
| Q2 24 | $7.3M | $21.9M | ||
| Q1 24 | $25.4M | $21.3M |
| Q4 25 | $-4.8M | $-75.0K | ||
| Q3 25 | $-638.0K | $-1.2M | ||
| Q2 25 | $-3.2M | $-2.0M | ||
| Q1 25 | $-1.2M | $-1.2M | ||
| Q4 24 | $-2.0M | $-907.0K | ||
| Q3 24 | $-5.7M | $-1.2M | ||
| Q2 24 | $-5.6M | $-2.2M | ||
| Q1 24 | $12.8M | $-971.0K |
| Q4 25 | — | 87.6% | ||
| Q3 25 | — | 86.4% | ||
| Q2 25 | — | 86.7% | ||
| Q1 25 | — | 87.7% | ||
| Q4 24 | — | 88.2% | ||
| Q3 24 | — | 86.1% | ||
| Q2 24 | — | 84.5% | ||
| Q1 24 | — | 85.3% |
| Q4 25 | -18.5% | -2.6% | ||
| Q3 25 | -1.5% | -5.0% | ||
| Q2 25 | -28.3% | -8.9% | ||
| Q1 25 | -9.2% | -4.3% | ||
| Q4 24 | -11.8% | -7.1% | ||
| Q3 24 | -74.6% | -5.3% | ||
| Q2 24 | -69.4% | -9.1% | ||
| Q1 24 | 54.2% | -4.0% |
| Q4 25 | -34.7% | -0.3% | ||
| Q3 25 | -5.1% | -4.6% | ||
| Q2 25 | -32.7% | -8.3% | ||
| Q1 25 | -13.3% | -5.1% | ||
| Q4 24 | -25.0% | -3.8% | ||
| Q3 24 | -82.2% | -5.4% | ||
| Q2 24 | -76.5% | -9.9% | ||
| Q1 24 | 50.6% | -4.6% |
| Q4 25 | $-0.17 | $-0.02 | ||
| Q3 25 | $-0.02 | $-0.05 | ||
| Q2 25 | $-0.11 | $-0.07 | ||
| Q1 25 | $-0.04 | $-0.04 | ||
| Q4 24 | $-0.02 | $-0.03 | ||
| Q3 24 | $-0.21 | $-0.05 | ||
| Q2 24 | $-0.20 | $-0.09 | ||
| Q1 24 | $0.41 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $35.5M | $87.9M |
| Total Assets | $70.6M | $154.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $13.5M | ||
| Q3 25 | $21.9M | $14.2M | ||
| Q2 25 | $18.7M | $13.9M | ||
| Q1 25 | $22.7M | $13.1M | ||
| Q4 24 | $26.6M | $5.9M | ||
| Q3 24 | $40.3M | $4.4M | ||
| Q2 24 | $43.1M | $5.5M | ||
| Q1 24 | $51.2M | $8.6M |
| Q4 25 | — | — | ||
| Q3 25 | $19.4M | — | ||
| Q2 25 | $19.4M | — | ||
| Q1 25 | $19.4M | — | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $32.1M | — | ||
| Q2 24 | $31.8M | — | ||
| Q1 24 | $31.3M | — |
| Q4 25 | $35.5M | $87.9M | ||
| Q3 25 | $-4.5M | $86.3M | ||
| Q2 25 | $-7.5M | $85.7M | ||
| Q1 25 | $-5.9M | $87.0M | ||
| Q4 24 | $-5.9M | $80.7M | ||
| Q3 24 | $-5.2M | $81.2M | ||
| Q2 24 | $-1.4M | $82.1M | ||
| Q1 24 | $3.0M | $84.8M |
| Q4 25 | $70.6M | $154.6M | ||
| Q3 25 | $49.3M | $151.1M | ||
| Q2 25 | $44.9M | $147.0M | ||
| Q1 25 | $46.4M | $148.5M | ||
| Q4 24 | $44.9M | $141.2M | ||
| Q3 24 | $58.9M | $139.6M | ||
| Q2 24 | $63.2M | $142.1M | ||
| Q1 24 | $69.2M | $133.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 10.40× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $1.8M |
| Free Cash FlowOCF − Capex | — | $76.0K |
| FCF MarginFCF / Revenue | — | 0.3% |
| Capex IntensityCapex / Revenue | — | 6.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-377.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $1.8M | ||
| Q3 25 | $1.5M | $326.0K | ||
| Q2 25 | $-3.7M | $2.3M | ||
| Q1 25 | $-4.3M | $1.3M | ||
| Q4 24 | $-1.5M | $2.7M | ||
| Q3 24 | $-2.2M | $409.0K | ||
| Q2 24 | $-8.4M | $-2.1M | ||
| Q1 24 | $39.0M | $5.9M |
| Q4 25 | — | $76.0K | ||
| Q3 25 | — | $-1.6M | ||
| Q2 25 | — | $880.0K | ||
| Q1 25 | — | $268.0K | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $-952.0K | ||
| Q2 24 | — | $-3.5M | ||
| Q1 24 | — | $4.9M |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | -6.4% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | -4.3% | ||
| Q2 24 | — | -16.1% | ||
| Q1 24 | — | 22.8% |
| Q4 25 | — | 6.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.7% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 4.6% | ||
| Q3 24 | — | 6.2% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 5.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
GAIA
| US | $16.7M | 65% |
| Non Us | $8.8M | 35% |
